MediaPress Releases
 August 22, 2016

Vizient, Inc. Announces Aaron Gerber, MD, as the Newly Appointed President of Sg2

Irving, Texas (August 22, 2016) – Vizient, Inc. announced today that Aaron Gerber, MD, has been appointed president of Sg2, a Vizient company. In this new role, Dr Gerber will guide Sg2 to further expand their suite of analytics-based health care intelligence, helping hospitals and health systems integrate, prioritize and drive growth and performance across the continuum of care.

“I am very pleased that Aaron will be leading Sg2 as its president,” said Bharat Sundaram, Vizient’s president of analytic and advisory services. “He has the right mix of IQ and EQ and will do an excellent job of leading the team as we work together to help our members succeed in a rapidly changing environment.”

Prior to joining Sg2, Dr Gerber was a Partner in the Health and Life Sciences Practice at Oliver Wyman. In that role, he was responsible for selling and delivering strategy consulting engagements to leading healthcare providers.  In addition, he led a strategic initiative to help drive collaboration across the operating companies of Oliver Wyman’s parent, Marsh and McLennan Companies. Before that, Dr Gerber held senior leadership positions at Allscripts and Vanguard Health Systems. Earlier in his career, he was the co-founder and chief executive officer of a startup company in the health and wellness services space that was sold to Northwestern Memorial Hospital. Dr Gerber received his medical degree and a masters of business administration from Northwestern University.

“Sg2 delivers unparalleled depth and rigor in the insights and analytics for the members we serve,” Sundaram said. “By combining Sg2’s powerful market and strategic insights with Vizient’s leading clinical, operational and supply analytics, we have the power to help providers get a broad understanding of their opportunities so they can execute to their full potential.”

Sg2 came under the Vizient umbrella as part of the company’s acquisition of MedAssets’ Spend and Clinical Resource Management (SCM) segment earlier this year. Sg2’s analytics and expertise help providers understand broad market dynamics and capitalize on their opportunities for growth in a particular market.

All of Sg2’s solutions are designed within a System of CARE philosophy (Clinical Alignment and Resource Effectiveness), which weaves together pre-acute, acute and post-acute sites to provide care at the right location, with the right resources, at the right time. Sg2 helps organizations build and master their System of CARE across key strategic areas such as market and enterprise, care redesign and consumerism.

###

About Vizient, Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient serves a diverse membership and customer base which includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents almost $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as the recently acquired MedAssets’ Spend and Clinical Resource Management (SCM) segment, which includes Sg2. In 2016, Vizient received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient headquarters is based in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.

Contact

Vizient, Inc.
Angie Boliver, 972-830-7961
angie.boliver@vizientinc.com

 

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube